SAN DIEGO — The next advance in spinal cord stimulation (SCS) could be a closed-loop system that uses evoked compound action potentials (ECAPs) to maintain therapeutic activation, results of the phase ...
Closed-loop sensing capability instantly and automatically adjusts therapy while treating chronic pain DUBLIN, April 26, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare ...
Saluda Medical Pty. Ltd., of Artarmon, Australia, made waves in 2019, winning the CE mark for its Evoke closed-loop spinal cord stimulation (SCS) system. The good news kept coming following the ...
Includes 8 Oral Presentations and Award of Best Clinical Abstract ARTARMON, Australia, Jan. 21, 2020 /PRNewswire/ -- Saluda Medical Pty Limited ("Saluda Medical") today announced that data from ...
MINNEAPOLIS, Aug. 4, 2023 /PRNewswire/ -- Saluda Medical, Inc. ("Saluda Medical"), a global medical device company revolutionizing the field of neuromodulation with an emerging portfolio of therapies ...
A new loan agreement with Medtronic could help give Saluda Medical the boost it needs for the continued development of the Evoke ECAP-Controlled, Closed-Loop Spinal Cord Stimulation (SCS). Artarmon, ...
Chicago, Nov. 20, 2025 (GLOBE NEWSWIRE) -- The global internal neuromodulation devices market was valued at US$ 11.81 billion in 2024 and is expected to reach 44.57 billion by 2033, growing at a CAGR ...
Twelve physician groups expressed their “profound objection” to Humana’s classification of a spinal procedure as “unproven” in a letter to the healthcare insurer. The letter, sent Oct. 9 to Manisha ...
ARTARMON, Australia, Jan. 21, 2020 /PRNewswire/ -- Saluda Medical Pty Limited ("Saluda Medical") today announced that data from multiple studies evaluating the company's Evoke ® ECAP-Controlled, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback